| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.4 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.4 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |